INTRODUCTION
============

Hypertension is an independent risk factor for cardiovascular disease. Generally, hypertension demands high costs due to its complications as cerebrovascular disease, coronary artery disease, heart failure, chronic renal failure, and peripheral vascular disease ([@ref15]).

Hypertension is often associated with metabolic abnormalities such as dyslipidemia, impaired glucose tolerance, insulin resistance, and obesity ([@ref5]). Moreover, there is increasing evidence that oxidative stress and associated oxidative damage are mediators of vascular injury and therefore may be involved in the pathogenesis of hypertension ([@ref12]; [@ref22]; [@ref28]).

Reactive oxygen species (ROS) are constantly formed in aerobic organisms and play important roles in normal regulation of many physiological processes. However, at high levels, ROS are harmful and cause widespread damage to cells and tissues, and disrupt many physiological processes ([@ref13]). Overproduction of ROS or inefficient antioxidant defenses characterize oxidative stress. ROS may react with cellular components, especially lipids and proteins, causing tissue damage ([@ref19]), which is thought to be involved in the development and progression of hypertension ([@ref30]). In addition, under pathological conditions, superoxide decreases the bioavailability of nitric oxide (NO) contributing to vascular damage and renal dysfunction ([@ref26]).

Grapes are a rich dietary source of polyphenolic compounds, which have beneficial effects for human health and experimental models of chronic diseases ([@ref31]; [@ref38]; [@ref37]; Soares de [@ref32]). Consumption of polyphenols in large amounts reduces the incidence of cardiovascular diseases ([@ref34]; [@ref16]; [@ref14]). These benefits of polyphenols may be related to their antioxidant, vasodilator ([@ref21]; [@ref16]), and antihypertensive effects ([@ref31]; [@ref16]), and their roles in reducing serum cholesterol levels (de [@ref7]) and protecting against atherosclerotic plaque ([@ref36]; [@ref16]).

Previously, we have demonstrated that *Vitis vinifera* L. grape skin extract (ACH09) is predominantly composed of anthocyanins ([@ref20]), a large family of polyphenols. These natural compounds may be responsible for the antihypertensive effect of the extract in desoxycorticosterone acetate-salt and Nw-nitro-L-arginine methyl ester (L-NAME) experimental models ([@ref31]; [@ref33]). In addition, we have demonstrated that this extract induces a vasodilator response ([@ref31]), has an antioxidant effect ([@ref10]; Soares de [@ref32]; [@ref20]) and has a protective effect on the metabolism of adult offspring whose mothers were fed a high fat diet ([@ref20]).

However, effects of ACH09 on spontaneously hypertensive rats (SHR), an experimental model that mimics the main abnormalities of human essential hypertension, such as high peripheral vascular resistance, have not been investigated.

MATERIALS AND METHODS
=====================

Preparation of the grape skin extract (ACH09)
---------------------------------------------

*V. vinifera* L. (Vitaceae) was obtained from the South of Brazil. The dried and powdered skin were extracted in an aqueous solution at 100℃ with occasional shaking for 120 min. Aqueous extract was concentrated under a vacuum, introduced into an ion-exchange resin column (cationic), and washed sequentially with ethanol, ethanol/H~2~O (1:1), and H~2~O. The ethanolic and hydroalcoholic fractions were placed together and evaporated under vacuum at 60℃, followed by spray drying of the concentrated solution (inlet temperature 190℃ and outlet temperature 85℃). The fine powder (ACH09) obtained in the process was soluble in H~2~O, and contained about 30% of total polyphenols, according to the Folin-Ciocalteau procedure ([@ref29]).

Polyphenol analyses
-------------------

Analysis of the composition of ACH09 was performed by high-performance liquid chromatography (HPLC) as previously reported ([@ref20]). Briefly, HPLC analysis of the dried hydroalcoholic ACH09 involved dissolving 10 mg of the extract in 1 mL methanol:H~2~O (1:1) with 0.5% formic acid (HPLC quality). All compounds showed the same ultraviolet (UV) spectra in the LC/UV/diode array detector analysis that is characteristic of anthocyanins. The compounds were identified as peonidin-3-*O*-glucoside, petunidin-3-*O*-glucoside, malvidin-3-*O*-glucoside, and malvidin-3-(6-O-*trans*-*p*-coumaryl)-5-*O*-diglicoside. The composition of ACH09 was confirmed by comparison of retention time with UV and mass spectrometry (MS) data from the LC/UV/MS, using commercially available standards ([@ref20]).

Animals
-------

All experiments were reviewed and approved by the Ethics Committee for Experimental Animals Use and Care (CEUA) of the Institute of Biology Roberto Alcântara Gomes/Rio de Janeiro State University (protocol: CEUA/022/2010). Male Wistar (W) and spontaneously hypertensive rats (SHR) were obtained from the facilities at the Rio de Janeiro State University at 3 weeks of age. The animals were maintained under standard conditions (12-h light/dark cycles, 23±2℃, humidity 60±10%, and 15 min/h air exhaustion cycle) and were divided into 4 groups (n=7 for each group): Wistar and SHR that received ACH09 (200 mg/kg/d in drinking water) for 12 weeks (W-ACH09 and SHR-ACH09, respectively), and corresponding controls (W-C and SHR-C) that received only water during the experimental protocol. Fluid intake was recorded every two days.

Systolic blood pressure measurement
-----------------------------------

Systolic blood pressure (SBP) was measured by the tail-cuff method using Letica LE 5000 devices (Letica Scientific Instruments, Póvoa de Varzim, Portugal). Rats were trained before starting the experimental protocol so that blood pressure could be recorded consistently with minimal restraint and stress to the animals. SBP measurements were recorded at the end of the experimental period; just before the measurement of SBP, rats were kept at 30∼32℃ for 15 min to ensure the pulsations in the tail artery were detectable.

Plasma assays
-------------

After 12 weeks of treatment and when rats were 15 weeks of age, rats were fasted for 12 h and then anesthetized with thiopental (70 mg/kg i.p.). Blood samples were collected by aorta puncture and centrifuged at 3,000 rpm for 10 min at 4℃. Plasma samples were separated and then stored at −80℃. Plasma glucose, triglyceride, and total cholesterol levels were measured by a colorimetric assay (Gold Analisa Diagnóstica, Belo Horizonte, Brazil).

Determination of oxidative damage
---------------------------------

Lipid membrane damage was determined by analyzing the formation of products of lipid peroxidation \[2-thiobarbituric acid reactive substances (TBARS)\] in kidney homogenates and plasma. Briefly, samples were mixed with 1 mL of trichloroacetic acid 10%, and 1 mL of 0.67% thiobarbituric acid, and heated in a boiling water bath for 30 min. TBARS was determined by measuring the absorbance at 532 nm and the results were expressed in nmol/mg protein ([@ref9]).

Determination of antioxidant enzyme activity
--------------------------------------------

Superoxide dismutase (SOD) and catalase (CAT) activities were determined in kidney homogenates and plasma. SOD activity was assayed by measuring the inhibition of adrenaline auto-oxidation at an absorbance of 480 nm ([@ref2]). CAT activity was measured by the rate of decrease in hydrogen peroxide at 240 nm ([@ref1]). The total protein content in each sample was determined using the Bradford method ([@ref4]).

Statistical analysis
--------------------

Data are shown as mean±standard error of the mean (SEM). Differences among groups were analyzed by a one-way analysis of variance (one-way ANOVA), followed by the Bonferroni *post hoc* test using GraphPad Prism version 6 (GraphPad Software, La Jolla, CA, USA). Statistical significance was calculated at *P*\<0.05. Graphs were created using SigmaPlot version 12.0 (Systat Software, Inc., San Jose, CA, USA).

RESULTS
=======

Effect of ACH09 on SBP
----------------------

SBP (mm Hg) was significantly higher (*P*\<0.05, n=7) in the SHR-C group than in the Wistar groups at the end of the experimental protocol ([Fig. 1](#F1){ref-type="fig"}). Treatment with ACH09 prevented the increase in SBP (*P*\<0.05) in the SHR group, and there was no difference between the SHR group and the Wistar groups at the end of treatment.

Effect of ACH09 on blood glucose, triglyceride, and total cholesterol levels
----------------------------------------------------------------------------

Fasting glucose did not differ between the experimental groups (n=7, [Fig. 2A](#F2){ref-type="fig"}). Plasma triglyceride (n=7, [Fig. 2B](#F2){ref-type="fig"}) and total cholesterol (n=7, [Fig. 2C](#F2){ref-type="fig"}) levels were higher in the SHR-C group than in the Wistar group (*P*\<0.05). Treatment with ACH09 restored both total cholesterol and triglyceride concentrations (*P*\<0.05) to normal levels in the SHR group ([Fig. 2B](#F2){ref-type="fig"} and 2C).

Effect of ACH09 on oxidative damage
-----------------------------------

Oxidative damage, assessed by levels of TBARS, was evaluated in the plasma (n=7, [Fig. 3A](#F3){ref-type="fig"}) and kidneys (n=7, [Fig. 3B](#F3){ref-type="fig"}) from all groups. TBARS levels were significantly higher (*P*\<0.05) in the plasma from the SHR-C group than the Wistar groups ([Fig. 3A](#F3){ref-type="fig"}). Rats in the SHR-ACH09 showed lower levels of TBARS in plasma than the SHR-C group (*P*\<0.05). The levels of TBARS in the kidneys were significantly lower (*P*\<0.05) in the SHR-ACH09 group than in the SHR-C group, but there were no differences between the SHR-C and Wistar groups ([Fig. 3B](#F3){ref-type="fig"}).

Effect of ACH09 on antioxidant activity
---------------------------------------

SOD and CAT activities were evaluated in the plasma and kidneys of all groups. Rats in both the SHR-ACH09 and W-ACH09 groups showed increased (*P*\<0.05) SOD activity in both the plasma (n=7, [Fig. 4A](#F4){ref-type="fig"}) and kidneys (n=7, [Fig. 4B](#F4){ref-type="fig"}) compared with their respective controls. However, there was no difference in catalase activity in the plasma (n=7, [Fig. 4C](#F4){ref-type="fig"}) and kidneys (n=7, [Fig. 4D](#F4){ref-type="fig"}) between experimental groups.

DISCUSSION
==========

This study evaluated the effects of chronic treatment with a hydroalcoholic extract obtained from the *V. vinifera* grape skin (ACH09) on blood pressure, oxidative stress, and lipid profile in SHR. The main results demonstrate that ACH09 prevents development of hypertension, oxidative stress, and altered lipid profile in SHR, which demonstrates its potential beneficial use against cardiovascular diseases.

The most common form of human hypertension is primary or essential hypertension, which is best represented by genetic animal models of hypertension such as the SHR ([@ref25]). In SHR, blood pressure rises progressively from 4 weeks of age. Therefore, in this study, 3-week-old SHR rats were used as we could observe the protective effect of long-term intake of ACH09 on the development of hypertension.

These results indicate that systolic blood pressure is significantly elevated in adult SHR, as previously reported ([@ref11]; [@ref3]). We demonstrate for the first time that chronic treatment with ACH09 prevents development of hypertension in SHR. Levels of systolic blood pressure in SHR-ACH09 were not different from those of the Wistar groups. The antihypertensive effect of ACH09 has been previously demonstrated by our group in the models of hypertension induced by administration of desoxycorticosterone acetate-salt and L-NAME ([@ref31]; [@ref33]). Moreover, ACH09 has been shown to protect normally fed offspring of high fat-fed dams during lactation from phenotypic and metabolic characteristics of metabolic syndrome, including hypertension ([@ref10]).

The antihypertensive effect of ACH09 is likely mediated by endothelium-dependent vasodilation induced by the extract ([@ref31]). [@ref17] showed that ACH09 induces vasodilation of pre-constricted isolated mesenteric vascular beds, which is endothelium-dependent and mediated by the release of NO in combination with endothelium-derived hyperpolarizing factor.

Growing evidence suggests that oxidative stress is a crucial molecular mechanism involved in the pathogenesis of hypertension and hypertensive renal damage ([@ref12]; [@ref22]; [@ref18]; [@ref28]; [@ref35]). In the present study, we showed that the oxidative damage, assessed by levels of the lipid peroxidation marker TBARS, was increased in plasma of SHR with established hypertension, which is in agreement with previously published data ([@ref11]; [@ref27]). Interestingly, ACH09 extract significantly reduced TBARS plasma levels in SHR, thereby demonstrating an antioxidant effect. However, levels of TBARS in the kidneys of SHR did not differ from those of Wistar groups. In contrast, a previous study showed that SHR rats have increased oxidative damage in the kidney compared with control group ([@ref11]). The difference between our results and this previous may be explained by the animals' age. [@ref11] used 24-week-old SHR whereas 15-week-old rats were used in the present study. Although we did not observe increased lipid peroxidation in the kidneys of SHR compared with the controls, ACH09 reduced lipid peroxidation, which is associated with increased activity of SOD, the major antioxidant enzyme; these results suggest ACH09 may also show renoprotective effect. The antioxidant capacity of ACH09 has been reported in experimental models of obesity ([@ref6]; [@ref24]), diabetes (Soares de [@ref32]), and metabolic programming ([@ref20]), possibly attributable to anthocyanins, particularly peonidin, petunidin, and malvidins in ACH09 ([@ref20]). Therefore, in the present study, the antioxidant effect of ACH09 in SHR may be related to induction of SOD, which is the first line of defense against oxidative stress. We speculate that the reduced levels of superoxide may increase bioavailability of nitric oxide, an important vasodilator, thus contributing to the antihypertensive effect of ACH09.

Dyslipidemia is strongly associated with increased cardiovascular risk ([@ref23]). Therefore, the development of a new agent that can simultaneously lower blood pressure and improve lipid profile is important for treatment of cardiovascular disease and hypertension. In the present study, we observed high levels of plasma triglycerides and total cholesterol in SHR compared with Wistar groups. We also demonstrated that ACH09 has an important role in regulating lipid profile in SHR. The results showed that ACH09 decreased levels of triglycerides ant total cholesterol in SHR to levels similar to normotensive groups. In our previous studies, we observed a significant reduction in serum total cholesterol and triglycerides in mice fed a high-fat diet and treated with ACH09, suggesting ACH09 has lipid-lowering properties ([@ref6]; [@ref24]), related to the increased cholesterol excretion through ATP-binding cassette sub-family G member (ABCG) 5 and ABCG8 transporters in the liver ([@ref24]). Anthocyanins present in ACH09 ([@ref20]) may be responsible for this improvement in lipid profile since polyphenols, such as procyanidins from grape seed extracts, improve the hyperlipidemic state in the fructose-fed rat model ([@ref8]).

In summary, the findings from this study show that chronic treatment with ACH09 is protective against development of high blood pressure in spontaneously hypertensive rats, and that this effect may be related to antioxidant effect of superoxide dismutase. Moreover, the improvement in lipid profile may contribute to the protective cardiovascular effect. These preclinical results reveal the possibility for use of ACH09 in the prevention or treatment of hypertension in human.
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